StockSelector.com
  Research, Select, & Monitor Saturday, February 22, 2020 5:26:21 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
G1 Therapeutics, Inc.$17.96($.48)(2.60%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

G1 Therapeutics, Inc. has an overall rank of 2171 out of 6020 stocks based on 5 positive rankings and 2 negative rankings.

Positive Rankings
Target Prices
The average analysts' target price is $82.00 for G1 Therapeutics using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, G1 Therapeutics is ranked 7.
Oversold RSI
The 14 Day Relative-Strength Index for G1 Therapeutics is 26.2. An RSI below 30 indicates the stock is oversold. Among companies with a low RSI, G1 Therapeutics is ranked 142.
Low Put/Call
G1 Therapeutics has a low Put/Call ratio of 0.16 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, G1 Therapeutics is ranked 450.
Oversold Stochastics
G1 Therapeutics rank is 589
Low vPut/Call
G1 Therapeutics has a low Put/Call ratio of 0.31 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, G1 Therapeutics is ranked 652.
Negative Rankings
10 Day Loss
G1 Therapeutics rank is 324
90 Day Loss
G1 Therapeutics rank is 830







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2020 StockSelector.com. All rights reserved.